logo-loader
RNS
viewCircassia Group PLC

Circassia Group Plc - Further re Transfer of Assets

RNS Number : 0011O
Circassia Group Plc
27 May 2020
 

27 May 2020

Circassia Group plc

Further re Proposed Transfer of Assets

Circassia Group plc ("Circassia" or "the Company") today announces that the mandatory 30 day waiting period for US anti-trust clearance expired at midnight on 26 May.  Accordingly, the proposed transfer of the Tudorza and Duaklir assets to AstraZeneca first announced on 9 April 2020 is now expected to complete during the course of the next three days.

A further announcement will be made once completion has taken place.

-Ends-

For further information, please contact:

Circassia Group plc

 

Ian Johnson, Executive Chairman

 

 

c/o Peel Hunt

Michael Roller, CFO

 

 

 

Peel Hunt (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel / Oliver Jackson

 

 

 

finnCap (Joint Broker)

Tel: +44 (0) 20 7220 0500

Geoff Nash / Alice Lane

 

 

 

Numis Securities (Joint Broker)

Tel: +44 (0) 20 7260 1000

James Black / Duncan Monteith

 

 

                                                                        


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DISPPUWPAUPUPGQ

Quick facts: Circassia Group PLC

Price: 24.31

Market: LSE
Market Cap: £91.63 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE